Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Carcinoma, Non-Small-Cell Lung 762Lung Neoplasms 339Ovarian Neoplasms 318Breast Neoplasms 277Fallopian Tube Neoplasms 158Triple Negative Breast Neoplasms 143Small Cell Lung Carcinoma 140Neoplasms 134Squamous Cell Carcinoma of Head and Neck 122Carcinoma, Ovarian Epithelial 114Neoplasm Metastasis 84Head and Neck Neoplasms 80Endometrial Neoplasms 76Uterine Cervical Neoplasms 70Esophageal Neoplasms 70Adenocarcinoma of Lung 68Neuroblastoma 55Central Nervous System Neoplasms 52Lymphoma, Large B-Cell, Diffuse 49Carcinoma 49Brain Neoplasms 48Recurrence 47Prostatic Neoplasms 44Parkinson Disease 4, Autosomal Dominant Lewy Body 44Urinary Bladder Neoplasms 42Esophageal Squamous Cell Carcinoma 41Lymphoma 39Melanoma 35Carcinoma, Squamous Cell 33Lymphoma, Non-Hodgkin 31

Interventions

Saline Solution 3Carboplatin 2Bevacizumab 2talazoparib 1stenoparib 1senaparib 1sargramostim 1olaparib 1liposomal doxorubicin 1Tranexamic Acid 1Ropivacaine 1Paclitaxel 1Neoadjuvant Therapy 1Antineoplastic Agents 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Advanced Ovarian Cancer × Carboplatin × Clear all
NCT05794659 2023-07-20

Cornerstone4

Aston Sci. Inc.

Phase 2 Not yet recruiting
98 enrolled
Gynecologic

Advanced Ovarian Cancer

NCT01462149 2017-05-31

Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer

Asan Medical Center

Phase 2 Completed
43 enrolled
Gynecologic

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡